The U.S. FDA has issued an Emergency Use Authorization for Thermo Fisher Scientific’s new TaqPath Zika Virus Kit for the detection of RNA from Zika virus and diagnosis of Zika virus infection, in individuals meeting Centers for Disease Control and Prevention (CDC) Zika virus clinical and/or epidemiological criteria.   As the first authorized solution developed in a lyophilized format, the TaqPath Zika Virus Kit design supports the surge capacity and deployment needs unique to an outbreak respo...